The European Union is granting EUR 15 million to Syria’s Ministry of Health to improve the country’s health infrastructure.
A new 70-bed private hospital has opened in Homs, providing the country’s third largest city with a new state of the art health facility.
In a story published on July 26 we had reported that Syria became in 2009 a major source of medicines entering the European market in violation of intellectual property rights, according to the European Commission Customs Office.
Syria was the 4th largest source of medicines and the 5th largest source of body care items intercepted in 2009 by the EU customs for infringement of intellectual property rights.
The Syrian-Qatari Holding, Syria's largest holding company, has announced the signing of a definitive shareholder agreement with the Syrian-American Medical Center for the co-development of a medical centre in Damascus.
A new decree issued by the Syrian President last week will help better trace pharmaceutical imports and combat the trade in fake drugs.
The Ministry of Health has announced that the number of people having died from swine flu in Syria has reached 150.
Syria’s Minister of Health, Rida Said, announced last week that the number of people having died from swine flu in Syria had reached 50.
The Syrian Cabinet has confirmed the decision of the Syrian Jordanian Committee last October to lift restrictions on the trade of pharmaceuticals between the two countries.
A Presidential decree has banned smoking in all public spaces in Syria.
Syria's Ministry of Health has said that the total number of swine flu cases in the country has reached 37, out of which two patients died.
Siemens Healthcare Consulting has been appointed to design and supervise the construction of a private hospital in the city of Homs.
Syria's Ministry of Health has confirmed that the first case of swine flu was found in the country.
GlaxoSmithKline announced on July 02 that it was developing its business in the Middle East region through the purchase of the branded generics business of Bristol Myers Squibb (BMS) in Lebanon, Jordan, Syria, Libya and Yemen.
Two new Syrian drug manufacturers have been certified by EU-accredited inspectors to export their products to the European market.
EDU 2011 Aleppo
Sheraton Hotel Aleppo
Damascus Chamber of Commerce